Imad Ajjawi, Phd, Mba work email
- Valid
Imad Ajjawi, Phd, Mba personal email
Imad Ajjawi, Phd, Mba phone numbers
Biotechnology entrepreneur passionate about revolutionizing the biotech industry. Founded Denovium, an AI biotech company for protein discovery and design. Acquired by Absci. IPO less than a year later at a $1.5B pre-money valuation. Secured >$100M funds via strategic partnerships, M&A and VCs. Authored >25 patents and peer-reviewed manuscripts (see Google Scholar). Featured in WIRED, Forbes, Bloomberg, NPR, and other media outlets.
-
Ceo And Co-FounderRybodyn Inc.San Diego, Ca, Us
-
Co-Founder And CeoRybodyn Inc. Jun 2024 - PresentRyboDyn Inc. is targeting the dark proteome to make new immunotherapies. We are unlocking and validating previously undiscovered, disease-specific targets that will impact the treatment of cancer and autoimmune diseases by driving a new wave of targeted therapeutics. Our "targets-to-assets" therapeutics development program is supported by a scalable, in-house platform for lead discovery and optimization. We aim to deliver first-in-class assets that recognize these targets for treating solid tumors and diseases lacking effective treatment options.
-
Vp, Business DevelopmentAbsci Jan 2021 - Apr 2024Vancouver, Washington, UsAbsci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Responsible for business growth, executing sales and marketing plans, and seeking new strategic partnerships. Closed Absci's first multi-target AI discovery licensing and mAb co-development deals (11 total programs > 600M in deal size+ royalties) providing major revenue drivers. Additionally, closed 5 strategic partnerships with top tier Universities and cancer institutes, supported other marquee biopharma deals and Initial Public Offering (1.5B pre-money valuation fund raising >$235M). -
Co-Founder & Chief Business OfficerDenovium Inc. Aug 2018 - Jan 2021Acquired by AbSci. Denovium is an artificial intelligence company pioneering novel AI methods to accelerate innovation in biopharma. Denovium is building an artificial intelligence engine (Denovium Engine) capable of interpreting disparate biological data types to answer biology’s toughest questions. Denovium established 14 partnerships with leading biotech and pharma companies in specific areas of focus including gene discovery, protein engineering and genomic medicine. -
Co-Founder & CeoGlöbier Jan 2017 - Dec 2020San Diego, California, Us• Patent-pending, safe & FDA-approved formulation to make beverages glow-in-the-dark. • Glöbier, the world’s first glow-in-the-dark beer, launched commercially in Fall 2019. • 1st place Entrepreneur Challenge; 1st place StartR Demo Day (UCSD). Featured on ABC news. -
Senior Business Development ManagerSynthetic Genomics Jan 2017 - Jul 2018La Jolla, Ca, Us• Reporting directly to the CBO, responsible for providing strategic direction to SGI’s DNA technology, computational biology and biomanufacturing business units. • End-to-end evaluation of new business opportunities including assessments on commercial fit with strategy.• Develop and form strategic partnerships with key companies in pharmaceutical and life sciences industries. -
Genomics Lead - Algal BiofuelsSynthetic Genomics Oct 2014 - Jan 2017La Jolla, Ca, Us• Technical lead, awarded over $60 million in research funding through strategic partnerships.• Resident expert in algal biofuel technology, track record of achieving aggressive deliverables and milestones.• Evaluation of new business opportunities for scientific and commercial fit with strategy.• Quarterly reporting of key performance indicators to executives and external partners.• Genomics team lead directing research on genome engineering, gene-editing, next-gen sequencing, transcriptomics, proteomics, metabolomics, systems biology, epigenetics, metabolic engineering, synthetic biology, lipid biosynthesis, forward and reverse genetics.• Scientific achievements include first to develop high efficiency CRISPR/Cas9 systems in industrial algal species and development of engineered strains with doubled lipid productivity for algal biofuel production as a renewable source of transportation fuel. Work was featured in numerous prestigious media outlets including WIRED, Forbes, Bloomberg, KPBS and NPR.
-
Market Analyst ConsultantLocana Mar 2017 - Jun 2017Analyzed Ag-bio market needs to determine best fit for Locana’s CRISPR/RCas9 precision RNA-editing technology platform. Identified a promising $10 billion market segment providing fast path to commercialization and an early-mover advantage.
-
Technology Innovation ConsultantScripps Institution Of Oceanography Oct 2016 - Dec 2016La Jolla, Ca, UsAdvised startup companies with their pitch decks, providing guidance on market analysis and segmentation, business model generation and go-to-market strategies. -
Digital Marketing ConsultantManta Instruments Jun 2016 - Sep 2016Analyzed digital marketing platforms to expand MANTA’s customer base resulting in a marketing press release in the top academic journal Science with an estimated target customer base of 130,000 subscribers.
-
Sr. ScientistSynthetic Genomics 2012 - 2014La Jolla, Ca, Us
-
Scientist I/IiSynthetic Genomics 2010 - 2012La Jolla, Ca, Us
-
Post-Doctoral FellowMichigan State University Jan 2007 - Oct 2010East Lansing, Mi, Us• Advanced systems level understanding of chloroplast function through a functional genomics collaboration.• Developed a high-throughput fatty acid screen resulting in the discovery of a novel class of FA desaturases.
Imad Ajjawi, Phd, Mba Skills
Imad Ajjawi, Phd, Mba Education Details
-
University Of California, San Diego - Rady School Of ManagementMaster Of Business Administration - Mba -
Michigan State UniversityGenome Sciences/Genomics
-
University Of Nevada, RenoBiochemistry
Frequently Asked Questions about Imad Ajjawi, Phd, Mba
What company does Imad Ajjawi, Phd, Mba work for?
Imad Ajjawi, Phd, Mba works for Rybodyn Inc.
What is Imad Ajjawi, Phd, Mba's role at the current company?
Imad Ajjawi, Phd, Mba's current role is CEO and Co-Founder.
What is Imad Ajjawi, Phd, Mba's email address?
Imad Ajjawi, Phd, Mba's email address is ia****@****msu.edu
What is Imad Ajjawi, Phd, Mba's direct phone number?
Imad Ajjawi, Phd, Mba's direct phone number is +161660*****
What schools did Imad Ajjawi, Phd, Mba attend?
Imad Ajjawi, Phd, Mba attended University Of California, San Diego - Rady School Of Management, Michigan State University, University Of Nevada, Reno.
What are some of Imad Ajjawi, Phd, Mba's interests?
Imad Ajjawi, Phd, Mba has interest in Science And Technology, Environment, Health.
What skills is Imad Ajjawi, Phd, Mba known for?
Imad Ajjawi, Phd, Mba has skills like Molecular Biology, Genomics, Biochemistry, Biotechnology, Protein Expression, Data Analysis, Project Management, Project Planning, Business Development, Business Strategy, Business Management, Project Coordination.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial